New Key Statistics Module, Z-Score and F-Score
NAS:DAWN Key Ratios
| Market Cap $ M | 1,385.22 |
| Enterprise Value $ M | 1,023.54 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.91 |
| Price/Sales | 145.43 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 8.00 |
| EPS (TTM) $ | -1.95 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.36 |
| EV-to-EBITDA | -3.37 |
| PEG | -- |
| Shares Outstanding M | 98.31 |
| Net Margin (%) | -2,044.43 |
| Operating Margin % | -3,570.91 |
| Pre-tax Margin (%) | -2,025.49 |
| Quick Ratio | 4.09 |
| Current Ratio | 4.09 |
| ROA % (ttm) | -42.55 |
| ROE % (ttm) | -47.42 |
| ROIC % (ttm) | -5,285.98 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.29 |
DAWN Number of Guru Trades
DAWN Volume of Guru Trades
Gurus Latest Trades with NAS:DAWN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:DAWN is held by these investors
Total 1
Day One Biopharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:DAWN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers